We’re looking for adults with moderate to severe itching due to cholestatic liver disease.
Join an at-home, paid research study.
Call 855-235-3143 or email pruritus@science37.com to see if you qualify.
SCIENCE 37
Enrolling Studies
SCIENCE 37
Enrolling Studies
We are no longer recruiting for this clinical trial. Please don’t let this be goodbye though! We have many other studies you may be eligible for. See below for the list of active and enrolling clinical trials. Explore other opportunities today.
We are no longer recruiting for this clinical trial. Please don’t let this be goodbye though! We have many other studies you may be eligible for. See below for the list of active and enrolling clinical trials. Explore other opportunities today.
Learn Why our Clients Trust Us
[The Science 37] Metasite strategy complements the conventional site mix to accelerate the recruitment of patients in remote locations and in underrepresented communities.
“[The Science 37] Metasite strategy complements the conventional site mix to accelerate the recruitment of patients in remote locations and in underrepresented communities.”
IDC Real-World Evidence, Social Determinants of Health, and Digital Biomarkers in Driving Patient Recruitment, #US50382823, March 2023
Science 37 places a significant emphasis on training. Healthcare staff are trained on the platform used in clinical trials, ensuring that when the patient and provider come into contact during any DCT, the patient experience is easy, and the data collecte
“Science 37 places a significant emphasis on training. Healthcare staff are trained on the platform used in clinical trials, ensuring that when the patient and provider come into contact during any DCT, the patient experience is easy, and the data collected is accurate.”
GlobalData
Science 37 delivers a model that truly supports patient preference—providing access through the site or through a DCT model. The patient’s choice is front and center.
“Science 37 delivers a model that truly supports patient preference—providing access through the site or through a DCT model. The patient’s choice is front and center.”
Clinical Trial Sponsor